General Information of Drug Transporter (DT)
DT ID DTD0128 Transporter Info
Gene Name SLC19A3
Transporter Name Thiamine transporter 2
Gene ID
80704
UniProt ID
Q9BZV2
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Chemical Compound

  DT Modulation1

NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Valproic Acid affects the expression of SLC19A3 mRNA [35]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Benzo(a)pyrene results in increased methylation of SLC19A3 5' UTR [24]

Regulation Mechanism

Transcription Factor Info

  1-Methyl-4-phenylpyridinium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

SLC19A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium [21]

Regulation Mechanism

Transcription Factor Info

  4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  abrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

abrine results in decreased expression of SLC19A3 mRNA [22]

Regulation Mechanism

Transcription Factor Info

  ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of SLC19A3 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  Amprolium

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  beta-Naphthoflavone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

beta-Naphthoflavone results in decreased expression of SLC19A3 mRNA [19]

Regulation Mechanism

Transcription Factor Info

  bisphenol A

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol A co-treated with Fulvestrant results in decreased methylation of SLC19A3 gene [25]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

bisphenol A results in increased expression of SLC19A3 mRNA [17]

Regulation Mechanism

Transcription Factor Info

  bisphenol S

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol S results in increased expression of SLC19A3 mRNA [17]

Regulation Mechanism

Transcription Factor Info

  Cadmium Chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cadmium Chloride results in increased expression of SLC19A3 mRNA [26]

Regulation Mechanism

Transcription Factor Info

  CGP 52608

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CGP 52608 promotes the reaction RORA protein binds to SLC19A3 gene [27]

Regulation Mechanism

Transcription Factor Info

  Chloroquine

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  Deferoxamine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Deferoxamine results in decreased expression of SLC19A3 mRNA [28]

Regulation Mechanism

Transcription Factor Info

  dorsomorphin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  entinostat

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

entinostat results in increased expression of SLC19A3 mRNA [5]

Regulation Mechanism

Transcription Factor Info

  Estradiol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Estradiol co-treated with TGFB1 protein results in decreased expression of SLC19A3 mRNA [29]

Regulation Mechanism

Transcription Factor Info

  Famotidine

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

SLC19A3 protein results in increased uptake of Famotidine [21]

Regulation Mechanism

Transcription Factor Info

  FR900359

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

FR900359 results in decreased phosphorylation of SLC19A3 protein [30]

Regulation Mechanism

Transcription Factor Info

  Fulvestrant

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol A co-treated with Fulvestrant results in decreased methylation of SLC19A3 gene [25]

Regulation Mechanism

Transcription Factor Info

  Oxygen

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

HIF1A protein affects the reaction Oxygen deficiency results in decreased expression of SLC19A3 protein [28]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Oxygen deficiency results in decreased expression of SLC19A3 mRNA [28]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Oxygen deficiency results in decreased expression of SLC19A3 protein [28]

Regulation Mechanism

Transcription Factor Info

  perfluorooctane sulfonic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perfluorooctane sulfonic acid results in decreased expression of SLC19A3 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  perfluorooctanoic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perfluorooctanoic acid results in decreased expression of SLC19A3 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  Phenformin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  pirinixic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pirinixic acid binds to and results in increased activity of PPARA protein which results in increased expression of SLC19A3 mRNA [32]

Regulation Mechanism

Transcription Factor Info

  sodium arsenite

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite affects the methylation of SLC19A3 gene [33]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

sodium arsenite results in increased expression of SLC19A3 mRNA [15]

Regulation Mechanism

Transcription Factor Info

  Thiamine

           9 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Metformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

SLC19A3 protein results in increased uptake of Thiamine [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

Thiamine deficiency results in increased expression of SLC19A3 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Thiamine deficiency results in increased expression of SLC19A3 protein [34]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

trichostatin A results in increased expression of SLC19A3 mRNA [16]

Regulation Mechanism

Transcription Factor Info

  Verapamil

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  Vitamin K 3

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vitamin K 3 affects the expression of SLC19A3 mRNA [2]

Regulation Mechanism

Transcription Factor Info

Mycotoxins

  aflatoxin B2

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

aflatoxin B2 results in decreased methylation of SLC19A3 intron [23]

Regulation Mechanism

Transcription Factor Info

Approved Drug

  Phenobarbital

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phenobarbital affects the expression of SLC19A3 [1]

  Hydrogen Peroxide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Hydrogen Peroxide affects the expression of SLC19A3 [2]

  Menadione

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Menadione affects the expression of SLC19A3 [2]

  Zidovudine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Zidovudine inhibits the expression of SLC19A3 [3]

  Panobinostat

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Panobinostat increases the expression of SLC19A3 [4]

  Vorinostat

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vorinostat increases the expression of SLC19A3 [5]

  Cisplatin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cisplatin inhibits the expression of SLC19A3 [6]

  Urethane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Urethane inhibits the expression of SLC19A3 [7]

  Acetaminophen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acetaminophen inhibits the expression of SLC19A3 [8]

  Cyclosporine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyclosporine inhibits the expression of SLC19A3 [9]

  Valproic Acid

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Valproic Acid increases the expression of SLC19A3 [10]

  Metformin

           8 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Metformin inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Metformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Metformin [21]

Regulation Mechanism

Transcription Factor Info

Drug in Phase 2 Trial

  Ethanol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ethanol inhibits the expression of SLC19A3 [11]

Regulation Mechanism

via the inhibition of Transcription factor Sp1 (SP1) Transcription Factor Info

Cell System

Mouse pancreatic acinar neoplasm cells (266-6)

  MS-275

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

MS-275 increases the expression of SLC19A3 [5]

  Bisphenol A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bisphenol A increases the expression of SLC19A3 [17]

Drug in Phase 1 Trial

  Quercetin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Quercetin increases the expression of SLC19A3 [14]

  Sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium arsenite increases the expression of SLC19A3 [15]

  Trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Trichostatin A increases the expression of SLC19A3 [16]

Investigative Drug

  Beta-naphthoflavone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Beta-naphthoflavone inhibits the expression of SLC19A3 [19]

  Vitamin B1

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

[3H]Thiamine modulates the activity of SLC19A3 [20]

Acute Toxic Substance

  Cadmium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cadmium inhibits the expression of SLC19A3 [13]

Carcinogen

  Benzo(a)pyrene

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzo(a)pyrene inhibits the expression of SLC19A3 [12]

  Nickel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nickel results in decreased expression of SLC19A3 mRNA [31]

Regulation Mechanism

Transcription Factor Info

Health and Environmental Toxicant

  Perfluorooctane sulfonic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Perfluorooctane sulfonic acid inhibits the expression of SLC19A3 [18]
References
1 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75.
2 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203.
3 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23.
4 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
5 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
6 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
7 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
8 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
9 Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
10 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
11 Mechanisms involved in the inhibitory effect of chronic alcohol exposure on pancreatic acinar thiamin uptake. Am J Physiol Gastrointest Liver Physiol. 2014 Apr 1;306(7):G631-9.
12 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
13 Microarray analysis of gene expression patterns in human proximal tubule cells over a short and long time course of cadmium exposure. J Toxicol Environ Health A. 2011;74(1):24-42.
14 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
15 Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer. Metallomics. 2012 Aug;4(8):784-93.
16 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
17 Bisphenol A and Bisphenol S Induce Distinct Transcriptional Profiles in Differentiating Human Primary Preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
18 An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model. Environ Toxicol. 2020 Dec;35(12):1395-1405.
19 Aryl hydrocarbon receptor (AhR) agonist beta-naphthoflavone regulated gene networks in human primary trophoblasts. Reprod Toxicol. 2020 Sep;96:370-379.
20 SLC19A3 encodes a second thiamine transporter ThTr2. Biochim Biophys Acta. 2001 Nov 29;1537(3):175-8.
21 Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). Mol Pharm. 2015 Dec 7;12(12):4301-10.
22 Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells. Toxicol Lett. 2019;312:1-10.
23 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018;121:214-223.
24 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017;8(1):1369-1391.
25 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019;11(1):138.
26 High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals. Environ Health Perspect. 2024;132(4):47002.
27 Identification of potential target genes of ROR-alpha in THP1 and HUVEC cell lines. Exp Cell Res. 2017;353(1):6-15.
28 Hypoxia inhibits colonic uptake of the microbiota-generated forms of vitamin B1 via HIF-1alpha-mediated transcriptional regulation of their transporters. J Biol Chem. 2022 Feb;298(2):101562.
29 Transforming growth factor beta1 targets estrogen receptor signaling in bronchial epithelial cells. Respir Res. 2018 Aug 30;19(1):160.
30 Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses. Mol Cell Proteomics. 2023;22(11):100649.
31 Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J Allergy Clin Immunol. 2015;135(3):712-20.
32 Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One. 2009;4(8):e6796.
33 Microarray dataset of transient and permanent DNA methylation changes in HeLa cells undergoing inorganic arsenic-mediated epithelial-to-mesenchymal transition. Data Brief. 2017;13:6-9.
34 Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms. Am J Physiol Renal Physiol. 2006;291(4):F796-805.
35 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.